Foresite Capital Management IV as of Sept. 30, 2022
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 8 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 37.2 | $116M | 9.7M | 11.95 | |
| Lyell Immunopharma (LYEL) | 23.6 | $73M | 10M | 7.33 | |
| Aclaris Therapeutics (ACRS) | 14.2 | $44M | 2.8M | 15.74 | |
| Kura Oncology (KURA) | 8.1 | $25M | 1.8M | 13.66 | |
| Pharvaris N V (PHVS) | 8.0 | $25M | 3.2M | 7.67 | |
| Syndax Pharmaceuticals (SNDX) | 5.3 | $17M | 690k | 24.03 | |
| Cymabay Therapeutics | 2.0 | $6.3M | 1.8M | 3.50 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 1.6 | $4.9M | 1.8M | 2.75 |
